aimed to investigate patients with Rett syndrome for comorbidities, including endocrine disruption.[125] In a cohort of 50 patients (46 females), 74.5% of whom had pathogenic variants in MECP2, almost half of patients experienced menstrual cycle disruption, including oligomenorrhea and secondary amenorrhea. The gene discussed is MECP2; the disease is Rett syndrome.